Vaginal misoprostol versus dinoprostone for the management of missed abortion.
D000020:Abortifacient Agents, Nonsteroidal / Q000008:administration & dosage* / Q000009:adverse effects; D000030:Abortion, Missed / Q000628:therapy*; D000282:Administration, Intravaginal; D004107:Dilatation and Curettage / Q000706:statistics & numerical data; D015232:Dinoprostone / Q000008:administration & dosage* / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007902:Length of Stay / Q000706:statistics & numerical data; D016595:Misoprostol / Q000008:administration & dosage* / Q000009:adverse effects; D010120:Oxytocics / Q000008:administration & dosage* / Q000009:adverse effects; D017060:Patient Satisfaction / Q000706:statistics & numerical data; D011247:Pregnancy; D011446:Prospective Studies; D013607:Tablets; D014592:Uterine Hemorrhage / Q000209:etiology
D000020:Abortifacient Agents, Nonsteroidal; D010120:Oxytocics; D013607:Tablets; D016595:Misoprostol; D015232:Dinoprostone